Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Third phase III trial under way for INS-365 Ophthalmic in dry eye

April 9, 2002

Antiangiogenic effects demonstrated for CA4P in mouse model of proliferative retinopathy

April 4, 2002

Sucampo licenses development and marketing rights to eye drop formulation of tacrolimus

April 2, 2002

ISTA reports preliminary phase III results for Vitrase

March 28, 2002

ISTA updates clinical progress of Vitrase

March 19, 2002

Inhibition of iNOS provides neuroprotection in glaucoma

March 11, 2002

Functional and morphological effects of Epitalon in rat model of retinitis pigmentosa

March 11, 2002

Russian research yields polypeptide complex with efficacy in exudative AMD

March 11, 2002

ISTA commences analysis of phase III Vitrase data

March 11, 2002

Allopurinol exerts immunomodulating effects in experimental autoimmune uveitis

March 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...